HCPCS Level II code A2006 designates the Novosorb synpath dermal matrix, billed per square centimeter as an add-on to a primary procedure. This code matters nationally because dermal matrices are increasingly used in complex wound care and reconstructive procedures, affecting facility and professional billing across hospital outpatient departments and ambulatory surgery centers. Accurate reporting of an add-on product per square centimeter influences claim completeness and aggregation of product utilization data.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The overview addresses payer coverage patterns, billing considerations for add-on per-unit products, and how facilities capture product use at the claim line level.

Readers will learn the clinical context for use of a dermal matrix product, the service settings where A2006 is most often reported, common billing modifiers and claim-line practices (listed separately), and which data elements are typically needed to support coverage and payment. The summary also highlights where input data is not available and directs readers to seek payer-specific policy language for coverage determinations. This national-level brief is focused on coding and billing context rather than clinical guidance.